Related Experiment Video
Updated: Jan 6, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
Building states' capacity to address dementia
John Shean1, Kina White2, Kristen Felten3
1Healthy Brain Initiative, Alzheimer's Association, Chicago, Illinois, United States.
The Gerontologist
|October 1, 2025
Summary
The Building Our Largest Dementia (BOLD) Infrastructure program elevates dementia as a public health priority. It supports health departments nationwide in developing action plans for risk reduction, early detection, and caregiving.
Area of Science:
- Public Health
- Gerontology
- Health Policy
Background:
- Dementia poses a significant public health challenge in the United States.
- There is a need to integrate dementia as a public health priority within various governmental structures.
- The Healthy Brain Initiative Road Map Series provides a framework for dementia-related public health actions.
Purpose of the Study:
- To describe the reach and impact of the Building Our Largest Dementia (BOLD) Infrastructure program.
- To highlight state-level strategies for advancing dementia as a public health priority.
- To showcase diverse approaches to dementia risk reduction, early detection, and caregiver support.
Main Methods:
- The study reviews the implementation of the BOLD Program since 2020.
- It analyzes the support provided to 45 state and other health departments.
- Exemplars of state-level initiatives are presented to illustrate program activities.
Main Results:
- The BOLD Program has supported numerous health departments in developing dementia action plans.
- Initiatives include engaging Geriatric Workforce Enhancement Programs for age-friendly systems.
- Efforts involve faith-based communities for risk reduction and training county staff for caregiver support.
Conclusions:
- The BOLD Program effectively promotes dementia as a public health issue across diverse communities.
- State and local health departments are implementing varied strategies tailored to their specific needs.
- Continued support and adaptation are crucial to address the diverse challenges in dementia public health action.
Related Concept Videos
Dementia
480
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
480
Alzheimer's Disease: Overview
1.5K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Cognitive Development During Adulthood
737
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
737
Alzheimer's Disease: Treatment
736
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
736
Aging
552
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
552
Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K

